ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastric Motility Disorder Drug Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-18K7253
Home | Market Reports | Health| Health Conditions
Global Gastric Motility Disorder Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Gastric Motility Disorder Drug Market Research Report 2025

Code: QYRE-Auto-18K7253
Report
September 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Theravance Inc
Helsinn Healthcare S.A.
Concert Pharmaceuticals Inc
Targacept, Inc.
ChironWells GmbH

Gastric Motility Disorder Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gastric Motility Disorder Drug Market

Gastric Motility Disorder Drug Market

The global market for Gastric Motility Disorder Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastric Motility Disorder Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Motility Disorder Drug.
The Gastric Motility Disorder Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastric Motility Disorder Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastric Motility Disorder Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gastric Motility Disorder Drug Market Report

Report Metric Details
Report Name Gastric Motility Disorder Drug Market
CAGR 5%
Segment by Type
  • Velusetrag
  • Ipamorelin
  • TD-8954
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Home Use
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Theravance, Inc., Helsinn Healthcare S.A., Concert Pharmaceuticals, Inc., Targacept, Inc., ChironWells GmbH
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gastric Motility Disorder Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gastric Motility Disorder Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Gastric Motility Disorder Drug Market report?

Ans: The main players in the Gastric Motility Disorder Drug Market are Theravance, Inc., Helsinn Healthcare S.A., Concert Pharmaceuticals, Inc., Targacept, Inc., ChironWells GmbH

What are the Application segmentation covered in the Gastric Motility Disorder Drug Market report?

Ans: The Applications covered in the Gastric Motility Disorder Drug Market report are Hospital, Clinic, Home Use

What are the Type segmentation covered in the Gastric Motility Disorder Drug Market report?

Ans: The Types covered in the Gastric Motility Disorder Drug Market report are Velusetrag, Ipamorelin, TD-8954, Others

1 Gastric Motility Disorder Drug Market Overview
1.1 Product Definition
1.2 Gastric Motility Disorder Drug by Type
1.2.1 Global Gastric Motility Disorder Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Velusetrag
1.2.3 Ipamorelin
1.2.4 TD-8954
1.2.5 Others
1.3 Gastric Motility Disorder Drug by Application
1.3.1 Global Gastric Motility Disorder Drug Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Use
1.4 Global Gastric Motility Disorder Drug Market Size Estimates and Forecasts
1.4.1 Global Gastric Motility Disorder Drug Revenue 2020-2031
1.4.2 Global Gastric Motility Disorder Drug Sales 2020-2031
1.4.3 Global Gastric Motility Disorder Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gastric Motility Disorder Drug Market Competition by Manufacturers
2.1 Global Gastric Motility Disorder Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gastric Motility Disorder Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gastric Motility Disorder Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gastric Motility Disorder Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastric Motility Disorder Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastric Motility Disorder Drug, Product Type & Application
2.7 Global Key Manufacturers of Gastric Motility Disorder Drug, Date of Enter into This Industry
2.8 Global Gastric Motility Disorder Drug Market Competitive Situation and Trends
2.8.1 Global Gastric Motility Disorder Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastric Motility Disorder Drug Players Market Share by Revenue
2.8.3 Global Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastric Motility Disorder Drug Market Scenario by Region
3.1 Global Gastric Motility Disorder Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gastric Motility Disorder Drug Sales by Region: 2020-2031
3.2.1 Global Gastric Motility Disorder Drug Sales by Region: 2020-2025
3.2.2 Global Gastric Motility Disorder Drug Sales by Region: 2026-2031
3.3 Global Gastric Motility Disorder Drug Revenue by Region: 2020-2031
3.3.1 Global Gastric Motility Disorder Drug Revenue by Region: 2020-2025
3.3.2 Global Gastric Motility Disorder Drug Revenue by Region: 2026-2031
3.4 North America Gastric Motility Disorder Drug Market Facts & Figures by Country
3.4.1 North America Gastric Motility Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gastric Motility Disorder Drug Sales by Country (2020-2031)
3.4.3 North America Gastric Motility Disorder Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gastric Motility Disorder Drug Market Facts & Figures by Country
3.5.1 Europe Gastric Motility Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gastric Motility Disorder Drug Sales by Country (2020-2031)
3.5.3 Europe Gastric Motility Disorder Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastric Motility Disorder Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Gastric Motility Disorder Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gastric Motility Disorder Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Gastric Motility Disorder Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gastric Motility Disorder Drug Market Facts & Figures by Country
3.7.1 Latin America Gastric Motility Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gastric Motility Disorder Drug Sales by Country (2020-2031)
3.7.3 Latin America Gastric Motility Disorder Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastric Motility Disorder Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastric Motility Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gastric Motility Disorder Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastric Motility Disorder Drug Sales by Type (2020-2031)
4.1.1 Global Gastric Motility Disorder Drug Sales by Type (2020-2025)
4.1.2 Global Gastric Motility Disorder Drug Sales by Type (2026-2031)
4.1.3 Global Gastric Motility Disorder Drug Sales Market Share by Type (2020-2031)
4.2 Global Gastric Motility Disorder Drug Revenue by Type (2020-2031)
4.2.1 Global Gastric Motility Disorder Drug Revenue by Type (2020-2025)
4.2.2 Global Gastric Motility Disorder Drug Revenue by Type (2026-2031)
4.2.3 Global Gastric Motility Disorder Drug Revenue Market Share by Type (2020-2031)
4.3 Global Gastric Motility Disorder Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gastric Motility Disorder Drug Sales by Application (2020-2031)
5.1.1 Global Gastric Motility Disorder Drug Sales by Application (2020-2025)
5.1.2 Global Gastric Motility Disorder Drug Sales by Application (2026-2031)
5.1.3 Global Gastric Motility Disorder Drug Sales Market Share by Application (2020-2031)
5.2 Global Gastric Motility Disorder Drug Revenue by Application (2020-2031)
5.2.1 Global Gastric Motility Disorder Drug Revenue by Application (2020-2025)
5.2.2 Global Gastric Motility Disorder Drug Revenue by Application (2026-2031)
5.2.3 Global Gastric Motility Disorder Drug Revenue Market Share by Application (2020-2031)
5.3 Global Gastric Motility Disorder Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Theravance, Inc.
6.1.1 Theravance, Inc. Company Information
6.1.2 Theravance, Inc. Description and Business Overview
6.1.3 Theravance, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Theravance, Inc. Gastric Motility Disorder Drug Product Portfolio
6.1.5 Theravance, Inc. Recent Developments/Updates
6.2 Helsinn Healthcare S.A.
6.2.1 Helsinn Healthcare S.A. Company Information
6.2.2 Helsinn Healthcare S.A. Description and Business Overview
6.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product Portfolio
6.2.5 Helsinn Healthcare S.A. Recent Developments/Updates
6.3 Concert Pharmaceuticals, Inc.
6.3.1 Concert Pharmaceuticals, Inc. Company Information
6.3.2 Concert Pharmaceuticals, Inc. Description and Business Overview
6.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product Portfolio
6.3.5 Concert Pharmaceuticals, Inc. Recent Developments/Updates
6.4 Targacept, Inc.
6.4.1 Targacept, Inc. Company Information
6.4.2 Targacept, Inc. Description and Business Overview
6.4.3 Targacept, Inc. Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Targacept, Inc. Gastric Motility Disorder Drug Product Portfolio
6.4.5 Targacept, Inc. Recent Developments/Updates
6.5 ChironWells GmbH
6.5.1 ChironWells GmbH Company Information
6.5.2 ChironWells GmbH Description and Business Overview
6.5.3 ChironWells GmbH Gastric Motility Disorder Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 ChironWells GmbH Gastric Motility Disorder Drug Product Portfolio
6.5.5 ChironWells GmbH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastric Motility Disorder Drug Industry Chain Analysis
7.2 Gastric Motility Disorder Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastric Motility Disorder Drug Production Mode & Process Analysis
7.4 Gastric Motility Disorder Drug Sales and Marketing
7.4.1 Gastric Motility Disorder Drug Sales Channels
7.4.2 Gastric Motility Disorder Drug Distributors
7.5 Gastric Motility Disorder Drug Customer Analysis
8 Gastric Motility Disorder Drug Market Dynamics
8.1 Gastric Motility Disorder Drug Industry Trends
8.2 Gastric Motility Disorder Drug Market Drivers
8.3 Gastric Motility Disorder Drug Market Challenges
8.4 Gastric Motility Disorder Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Theravance Inc
Helsinn Healthcare S.A.
Concert Pharmaceuticals Inc
Targacept, Inc.
ChironWells GmbH
List of Tables
 Table 1. Global Gastric Motility Disorder Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gastric Motility Disorder Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gastric Motility Disorder Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gastric Motility Disorder Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Gastric Motility Disorder Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gastric Motility Disorder Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gastric Motility Disorder Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gastric Motility Disorder Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gastric Motility Disorder Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gastric Motility Disorder Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gastric Motility Disorder Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Gastric Motility Disorder Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gastric Motility Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Motility Disorder Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gastric Motility Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gastric Motility Disorder Drug Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Gastric Motility Disorder Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Gastric Motility Disorder Drug Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Gastric Motility Disorder Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Gastric Motility Disorder Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gastric Motility Disorder Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Gastric Motility Disorder Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gastric Motility Disorder Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Gastric Motility Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gastric Motility Disorder Drug Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Gastric Motility Disorder Drug Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Gastric Motility Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gastric Motility Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gastric Motility Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gastric Motility Disorder Drug Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Gastric Motility Disorder Drug Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Gastric Motility Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gastric Motility Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gastric Motility Disorder Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gastric Motility Disorder Drug Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Gastric Motility Disorder Drug Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Gastric Motility Disorder Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gastric Motility Disorder Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gastric Motility Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gastric Motility Disorder Drug Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Gastric Motility Disorder Drug Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Gastric Motility Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gastric Motility Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gastric Motility Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Gastric Motility Disorder Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gastric Motility Disorder Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gastric Motility Disorder Drug Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Gastric Motility Disorder Drug Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Gastric Motility Disorder Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Gastric Motility Disorder Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Gastric Motility Disorder Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gastric Motility Disorder Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gastric Motility Disorder Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Gastric Motility Disorder Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Gastric Motility Disorder Drug Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Gastric Motility Disorder Drug Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Gastric Motility Disorder Drug Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Gastric Motility Disorder Drug Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Gastric Motility Disorder Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Gastric Motility Disorder Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Gastric Motility Disorder Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gastric Motility Disorder Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gastric Motility Disorder Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Gastric Motility Disorder Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Gastric Motility Disorder Drug Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Gastric Motility Disorder Drug Price (USD/Pcs) by Application (2026-2031)
 Table 70. Theravance, Inc. Company Information
 Table 71. Theravance, Inc. Description and Business Overview
 Table 72. Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Theravance, Inc. Gastric Motility Disorder Drug Product
 Table 74. Theravance, Inc. Recent Developments/Updates
 Table 75. Helsinn Healthcare S.A. Company Information
 Table 76. Helsinn Healthcare S.A. Description and Business Overview
 Table 77. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product
 Table 79. Helsinn Healthcare S.A. Recent Developments/Updates
 Table 80. Concert Pharmaceuticals, Inc. Company Information
 Table 81. Concert Pharmaceuticals, Inc. Description and Business Overview
 Table 82. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product
 Table 84. Concert Pharmaceuticals, Inc. Recent Developments/Updates
 Table 85. Targacept, Inc. Company Information
 Table 86. Targacept, Inc. Description and Business Overview
 Table 87. Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Targacept, Inc. Gastric Motility Disorder Drug Product
 Table 89. Targacept, Inc. Recent Developments/Updates
 Table 90. ChironWells GmbH Company Information
 Table 91. ChironWells GmbH Description and Business Overview
 Table 92. ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. ChironWells GmbH Gastric Motility Disorder Drug Product
 Table 94. ChironWells GmbH Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Gastric Motility Disorder Drug Distributors List
 Table 98. Gastric Motility Disorder Drug Customers List
 Table 99. Gastric Motility Disorder Drug Market Trends
 Table 100. Gastric Motility Disorder Drug Market Drivers
 Table 101. Gastric Motility Disorder Drug Market Challenges
 Table 102. Gastric Motility Disorder Drug Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gastric Motility Disorder Drug
 Figure 2. Global Gastric Motility Disorder Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastric Motility Disorder Drug Market Share by Type: 2024 & 2031
 Figure 4. Velusetrag Product Picture
 Figure 5. Ipamorelin Product Picture
 Figure 6. TD-8954 Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Gastric Motility Disorder Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Gastric Motility Disorder Drug Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Home Use
 Figure 13. Global Gastric Motility Disorder Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Gastric Motility Disorder Drug Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Gastric Motility Disorder Drug Sales (2020-2031) & (K Pcs)
 Figure 16. Global Gastric Motility Disorder Drug Average Price (USD/Pcs) & (2020-2031)
 Figure 17. Gastric Motility Disorder Drug Report Years Considered
 Figure 18. Gastric Motility Disorder Drug Sales Share by Manufacturers in 2024
 Figure 19. Global Gastric Motility Disorder Drug Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Gastric Motility Disorder Drug Players: Market Share by Revenue in Gastric Motility Disorder Drug in 2024
 Figure 21. Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Gastric Motility Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Gastric Motility Disorder Drug Sales Market Share by Country (2020-2031)
 Figure 24. North America Gastric Motility Disorder Drug Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Gastric Motility Disorder Drug Sales Market Share by Country (2020-2031)
 Figure 28. Europe Gastric Motility Disorder Drug Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Region (2020-2031)
 Figure 36. China Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Gastric Motility Disorder Drug Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Gastric Motility Disorder Drug Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Gastric Motility Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Gastric Motility Disorder Drug by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Gastric Motility Disorder Drug by Type (2020-2031)
 Figure 58. Global Gastric Motility Disorder Drug Price (USD/Pcs) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Gastric Motility Disorder Drug by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Gastric Motility Disorder Drug by Application (2020-2031)
 Figure 61. Global Gastric Motility Disorder Drug Price (USD/Pcs) by Application (2020-2031)
 Figure 62. Gastric Motility Disorder Drug Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions